Research ExplorerPublicationsMarrow fibrosis predicts early fatal marrow failure in patie...

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.

Standard

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. / Buesche, G; Teoman, H; Wilczak, Waldemar; Ganser, A; Hecker, H; Wilkens, L; Göhring, G; Schlegelberger, B; Bock, O; Georgii, A; Kreipe, H.

In: LEUKEMIA, Vol. 22, No. 2, 2, 2008, p. 313-322.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Buesche, G, Teoman, H, Wilczak, W, Ganser, A, Hecker, H, Wilkens, L, Göhring, G, Schlegelberger, B, Bock, O, Georgii, A & Kreipe, H 2008, 'Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.', LEUKEMIA, vol. 22, no. 2, 2, pp. 313-322. <http://www.ncbi.nlm.nih.gov/pubmed/18033321?dopt=Citation>

APA

Buesche, G., Teoman, H., Wilczak, W., Ganser, A., Hecker, H., Wilkens, L., Göhring, G., Schlegelberger, B., Bock, O., Georgii, A., & Kreipe, H. (2008). Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. LEUKEMIA, 22(2), 313-322. [2]. http://www.ncbi.nlm.nih.gov/pubmed/18033321?dopt=Citation

Vancouver

Buesche G, Teoman H, Wilczak W, Ganser A, Hecker H, Wilkens L et al. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. LEUKEMIA. 2008;22(2):313-322. 2.

Bibtex

@article{f1b2dea00f7743da8ca5736d66f4476d,
title = "Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.",
abstract = "Marrow fibrosis (MF) has rarely been studied in myelodysplastic syndromes (MDS). There are no data on occurrence and significance of MF in the context of the World Health Organization (WHO) classification of disease. In total, 349 bone marrow biopsies from 200 patients with primary MDS were examined for MF and its prognostic relevance. MF correlated with multilineage dysplasia, more severe thrombopenia, higher probability of a clonal karyotype abnormality, and higher percentages of blasts in the peripheral blood (P",
author = "G Buesche and H Teoman and Waldemar Wilczak and A Ganser and H Hecker and L Wilkens and G G{\"o}hring and B Schlegelberger and O Bock and A Georgii and H Kreipe",
year = "2008",
language = "Deutsch",
volume = "22",
pages = "313--322",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "2",

}

RIS

TY - JOUR

T1 - Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.

AU - Buesche, G

AU - Teoman, H

AU - Wilczak, Waldemar

AU - Ganser, A

AU - Hecker, H

AU - Wilkens, L

AU - Göhring, G

AU - Schlegelberger, B

AU - Bock, O

AU - Georgii, A

AU - Kreipe, H

PY - 2008

Y1 - 2008

N2 - Marrow fibrosis (MF) has rarely been studied in myelodysplastic syndromes (MDS). There are no data on occurrence and significance of MF in the context of the World Health Organization (WHO) classification of disease. In total, 349 bone marrow biopsies from 200 patients with primary MDS were examined for MF and its prognostic relevance. MF correlated with multilineage dysplasia, more severe thrombopenia, higher probability of a clonal karyotype abnormality, and higher percentages of blasts in the peripheral blood (P

AB - Marrow fibrosis (MF) has rarely been studied in myelodysplastic syndromes (MDS). There are no data on occurrence and significance of MF in the context of the World Health Organization (WHO) classification of disease. In total, 349 bone marrow biopsies from 200 patients with primary MDS were examined for MF and its prognostic relevance. MF correlated with multilineage dysplasia, more severe thrombopenia, higher probability of a clonal karyotype abnormality, and higher percentages of blasts in the peripheral blood (P

M3 - SCORING: Zeitschriftenaufsatz

VL - 22

SP - 313

EP - 322

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 2

M1 - 2

ER -